Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Nov;62 Suppl 2(Suppl 2):ii55-9.
doi: 10.1136/ard.62.suppl_2.ii55.

B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience

T Shaw  1 , J Quan, M C Totoritis
Affiliations
Review

B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience

T Shaw et al. Ann Rheum Dis. 2003 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Potential roles of B cells in RA.
Figure 2
Figure 2
Response to rituximab at six months in two independent studies each involving five patients with RA refractory to DMARD treatment treated (A) with or (B) without concomitant DMARD treatment.18,21
Figure 3
Figure 3
ACR responses at six months in an interim cohort of patients with RA refractory to DMARD treatment treated with rituximab with and without concomitant cyclophosphamide or methotrexate, compared with continuation of methotrexate alone.
See this image and copyright information in PMC

References

    1. BioDrugs. 2001;15(2):73-9 - PubMed
    1. Rheum Dis Clin North Am. 2001 May;27(2):335-53 - PubMed
    1. Nat Immunol. 2001 Sep;2(9):764-6 - PubMed
    1. J Immunol. 2001 Oct 15;167(8):4710-8 - PubMed
    1. Arthritis Rheum. 2001 Sep;44(9):2029-37 - PubMed

MeSH terms